Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.39 |
| ▸ | NTSR2 | O95665 | 2/20 | 0.38 |
| ▸ | NTSR1 | P30989 | 2/20 | 0.38 |
| ▸ | FURIN | P09958 | 1/20 | 0.38 |
| ▸ | C5AR1 | P21730 | 2/20 | 0.36 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.35 |
| ▸ | ITGAV | P06756 | 1/20 | 0.35 |
| ▸ | NPY1R | P25929 | 1/20 | 0.35 |
| ▸ | NPY2R | P49146 | 1/20 | 0.35 |
| ▸ | NPY4R | P50391 | 1/20 | 0.35 |
| ▸ | MME | P08473 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29732685 | 0.95 | SLC15A2 (0.44) | SLC15A2NTSR2NTSR1FURINC5AR1 | |
| SCHEMBL30296849 | 0.94 | SLC15A2 (0.38) | SLC15A2NTSR2NTSR1FURINC5AR1 | |
| SCHEMBL29531170 | 0.94 | SLC15A2 (0.39) | SLC15A2NTSR2NTSR1FURINC5AR1 | |
| SCHEMBL29622914 | 0.92 | SLC15A2 (0.38) | SLC15A2FURINITGB3ITGAV | |
| SCHEMBL30254475 | 0.89 | OPRM1 (0.39) | MME | |
| SCHEMBL30148442 | 0.89 | SLC15A2 (0.45) | SLC15A2NTSR2NTSR1C5AR1 | |
| SCHEMBL31472587 | 0.89 | SLC15A2 (0.42) | SLC15A2FURIN | |
| SCHEMBL29014883 | 0.89 | SLC15A2 (0.42) | SLC15A2FURIN | |
| SCHEMBL4200040 | 0.89 | CALCR (0.39) | SLC15A2ITGB3ITGAV | |
| SCHEMBL4200033 | 0.89 | CALCR (0.39) | SLC15A2ITGB3ITGAV |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4039710-B1 | ANTI-CD3 ANTIBODIES, ANTI-CD123 ANTIBODIES AND BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO CD3 AND/OR CD123 | SANOFI SA (FR) | 2026-03-25 | — | — | EP | disclosed |
| CN-116675776-A | Trispecific and/or trivalent binding proteins for the prevention or treatment of HIV infection | 赛诺菲 | 2023-09-01 | — | — | CN | disclosed |
| EP-4039710-A2 | ANTI-CD3 ANTIBODIES, ANTI-CD123 ANTIBODIES AND BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO CD3 AND/OR CD123 | SANOFI (FR) | 2022-08-10 | — | — | EP | disclosed |
| CN-114230668-A | anti-CD 3 antibodies, anti-CD 123 antibodies, and bispecific antibodies that specifically bind to CD3 and/or CD123 | 赛诺菲 | 2022-03-25 | — | — | CN | disclosed |
| CN-114230667-A | anti-CD 3 antibodies, anti-CD 123 antibodies, and bispecific antibodies that specifically bind to CD3 and/or CD123 | 赛诺菲 | 2022-03-25 | — | — | CN | disclosed |